These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25524547)

  • 1. Antiproliferative Effect of Novel Aminoacridine-based Compounds.
    Munder A; Moskovitz Y; Redko B; Levy AR; Ruthstein S; Gellerman G; Gruzman A
    Med Chem; 2015; 11(4):373-82. PubMed ID: 25524547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-Hydroxymethyl-3-aminoacridine derivatives as a new family of anticancer agents.
    Charmantray F; Demeunynck M; Carrez D; Croisy A; Lansiaux A; Bailly C; Colson P
    J Med Chem; 2003 Mar; 46(6):967-77. PubMed ID: 12620073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of amsacrine and other DNA-intercalating drugs on nuclear and nucleolar structure in cultured V79 Chinese hamster cells and PtK2 rat kangaroo cells.
    Jensen CG; Wilson WR; Bleumink AR
    Cancer Res; 1985 Feb; 45(2):717-25. PubMed ID: 3838148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expedient synthesis and anticancer evaluation of dual-action 9-anilinoacridine methyl triazene chimeras.
    Walunj D; Egarmina K; Tuchinsky H; Shpilberg O; Hershkovitz-Rokah O; Grynszpan F; Gellerman G
    Chem Biol Drug Des; 2021 Feb; 97(2):237-252. PubMed ID: 32772433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, antitumor activity, and DNA binding properties of a new derivative of amsacrine, N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino) phenylamino]-4-acridinecarboxamide.
    Baguley BC; Denny WA; Atwell GJ; Finlay GJ; Rewcastle GW; Twigden SJ; Wilson WR
    Cancer Res; 1984 Aug; 44(8):3245-51. PubMed ID: 6547635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of pyrrolo[2,3-b]pyridine analogues as antiproliferative agents and their interaction with calf thymus DNA.
    Narva S; Chitti S; Bala BR; Alvala M; Jain N; Kondapalli VG
    Eur J Med Chem; 2016 May; 114():220-31. PubMed ID: 26994690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the mutagenic and clastogenic activity of amsacrine and other DNA-intercalating drugs in cultured V79 Chinese hamster cells.
    Wilson WR; Harris NM; Ferguson LR
    Cancer Res; 1984 Oct; 44(10):4420-31. PubMed ID: 6547875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprotection by 9-aminoacridine derivatives against the cytotoxicity of topoisomerase II-directed drugs.
    Finlay GJ; Wilson WR; Baguley BC
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1695-701. PubMed ID: 2561099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential growth inhibition of cultured mammalian cells: comparison of clinical antitumour agents and amsacrine derivatives.
    Wilson WR; Tapp SM; Baguley BC
    Eur J Cancer Clin Oncol; 1984 Mar; 20(3):383-9. PubMed ID: 6546720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, antiproliferative activity and DNA binding properties of novel 5-aminobenzimidazo[1,2-a]quinoline-6-carbonitriles.
    Perin N; Nhili R; Ester K; Laine W; Karminski-Zamola G; Kralj M; David-Cordonnier MH; Hranjec M
    Eur J Med Chem; 2014 Jun; 80():218-27. PubMed ID: 24780599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA binding, cytotoxicity and inhibitory effect on RNA synthesis of two new 1-nitro-9-aminoacridine dimers.
    Markovits J; Wilmańska D; Lescot E; Studzian K; Szmigiero L; Gniazdowski M
    Chem Biol Interact; 1989; 70(1-2):73-87. PubMed ID: 2472225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of 4-(9-acridinylamino)aniline and derivatives with DNA. Influence of a lysylglycyl side chain on the binding parameters.
    Hénichart JP; Bernier JL; Catteau JP
    Hoppe Seylers Z Physiol Chem; 1982 Aug; 363(8):835-41. PubMed ID: 6896863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity.
    Bolognese A; Correale G; Manfra M; Lavecchia A; Mazzoni O; Novellino E; La Colla P; Sanna G; Loddo R
    J Med Chem; 2004 Feb; 47(4):849-58. PubMed ID: 14761187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cis-Dichloroplatinum(II) complexes tethered to 9-aminoacridine-4-carboxamides: synthesis and action in resistant cell lines in vitro.
    Holmes RJ; McKeage MJ; Murray V; Denny WA; McFadyen WD
    J Inorg Biochem; 2001 Jun; 85(2-3):209-17. PubMed ID: 11410241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of action of mAMSA.
    Marshall B; Ralph RK
    Adv Cancer Res; 1985; 44():267-93. PubMed ID: 3898738
    [No Abstract]   [Full Text] [Related]  

  • 16. A novel ruthenium(II) arene based intercalator with potent anticancer activity.
    Ruiz J; Vicente C; de Haro C; Bautista D
    Dalton Trans; 2009 Jul; (26):5071-3. PubMed ID: 19562164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel copper(II) complexes as new promising antitumour agents. A crystal structure of [Cu(1,10-phenanthroline-5,6-dione)2(OH2)(OClO3)](ClO4).
    Pivetta T; Trudu F; Valletta E; Isaia F; Castellano C; Demartin F; Tuveri R; Vascellari S; Pani A
    J Inorg Biochem; 2014 Dec; 141():103-113. PubMed ID: 25238635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acridine-based agents with topoisomerase II activity inhibit pancreatic cancer cell proliferation and induce apoptosis.
    Goodell JR; Ougolkov AV; Hiasa H; Kaur H; Remmel R; Billadeau DD; Ferguson DM
    J Med Chem; 2008 Jan; 51(2):179-82. PubMed ID: 18163538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual dynamics of killing of cultured Lewis lung cells by the DNA-intercalating antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.
    Haldane A; Finlay GJ; Gavin JB; Baguley BC
    Cancer Chemother Pharmacol; 1992; 29(6):475-9. PubMed ID: 1568291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, biological activity and DNA interaction of anilinoacridine and bithiazole peptide derivatives related to the anti-tumor drugs m-AMSA and bleomycin.
    Morier-Teissier E; Bailly C; Bernier JL; Houssin R; Helbecque N; Catteau JP; Colson P; Houssier C; Hénichart JP
    Anticancer Drug Des; 1989 Jun; 4(1):37-52. PubMed ID: 2474298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.